SODIUM POLYSTYRENE SULFONATE
These highlights do not include all the information needed to use sodium polystyrene sulfonate for suspension safely and effectively. See full prescribing information for sodium polystyrene sulfonate for suspension. Sodium polystyrene sulfonate for suspension, for oral or rectal useInitial U.S. Approval: 1958
Approved
Approval ID
c73b9661-2378-4336-8be0-098e7c1ae522
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Aug 12, 2022
Manufacturers
FDA
SUNRISE PHARMACEUTICAL, INC.
DUNS: 168522378
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
sodium polystyrene sulfonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code11534-166
Application NumberANDA204071
Product Classification
M
Marketing Category
C73584
G
Generic Name
sodium polystyrene sulfonate
Product Specifications
Route of AdministrationORAL, RECTAL
Effective DateApril 10, 2020
FDA Product Classification
INGREDIENTS (1)
SODIUM POLYSTYRENE SULFONATEActive
Quantity: 4.1 meq in 1 g
Code: 1699G8679Z
Classification: ACTIR